Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Affective Disorders
|
February 13, 2022
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review
Julia J Meerman, Sophie E Ter Hark, Joost G E Janzing, et al.
Journal of Psychiatric Research
|
April 9, 2022
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review
Sophie E Ter Hark, Cornelis F Vos, Rob E Aarnoutse, et al.
Clinical Pharmacokinetics
|
May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard Dosing
Cornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Brain, Behavior, & Immunity - Health
|
August 23, 2021
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis
Cornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Journal of Clinical Psychopharmacology
|
November 6, 2023
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression
Cornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Translational Psychiatry
|
March 2, 2024
A genetic risk score to predict treatment nonresponse in psychotic depression
Sophie E Ter Hark, Marieke J H Coenen, Cornelis F Vos, et al.
JAMA Network Open
|
May 8, 2023
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial
Cornelis F Vos, Sophie E Ter Hark, Arnt F A Schellekens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2025
Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: a trial-based economic evaluation
Sophie E Ter Hark, Wietske Kievit, Gerjon Hannink, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 5, 2020
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
Sophie E Ter Hark, Stéphane Jamain, Dick Schijven, et al.
BMC Psychiatry
|
October 2, 2021
Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
Cornelis F Vos, Rob E Aarnoutse, Marijke J M Op de Coul, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Affective Disorders
|
February 13, 2022
The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review
Julia J Meerman, Sophie E Ter Hark, Joost G E Janzing, et al.
Journal of Psychiatric Research
|
April 9, 2022
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review
Sophie E Ter Hark, Cornelis F Vos, Rob E Aarnoutse, et al.
Clinical Pharmacokinetics
|
May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard Dosing
Cornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Brain, Behavior, & Immunity - Health
|
August 23, 2021
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysis
Cornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Journal of Clinical Psychopharmacology
|
November 6, 2023
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression
Cornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Translational Psychiatry
|
March 2, 2024
A genetic risk score to predict treatment nonresponse in psychotic depression
Sophie E Ter Hark, Marieke J H Coenen, Cornelis F Vos, et al.
JAMA Network Open
|
May 8, 2023
Effectiveness of Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: A Randomized Clinical Trial
Cornelis F Vos, Sophie E Ter Hark, Arnt F A Schellekens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 6, 2025
Genotype-Specific Tricyclic Antidepressant Dosing in Patients With Major Depressive Disorder: a trial-based economic evaluation
Sophie E Ter Hark, Wietske Kievit, Gerjon Hannink, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 5, 2020
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)
Sophie E Ter Hark, Stéphane Jamain, Dick Schijven, et al.
BMC Psychiatry
|
October 2, 2021
Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
Cornelis F Vos, Rob E Aarnoutse, Marijke J M Op de Coul, et al.
Page
of 1